As patients lose weight, One Medical clinicians adjust medications for conditions like high blood pressure or diabetes when appropriate
Multiple randomised, placebo-controlled trials have tested GLP-1 drugs as add-on therapy to insulin in people with T1D, and the picture that emerges is consistent, if modest: meaningful weight loss, real reductions in daily insulin needs, and improvements in CGM time in range
Interest is understandable, but a compound being discussed online is not the same as a compound you can responsibly obtain, and that distinction matters for anyone evaluating a program
Goldstein AL, Hannappel E, Sosne G, Kleinman HK (2012)
In rare cases, more serious side effects may occur